Human chromosome 1p35-p36 has long been suspected to harbor a tumor suppressor gene in pancreatic cancer and other tumors. We found that expression of rap1GAP, a gene located in this chromosomal region, is significantly down-regulated in pancreatic cancer. Only a small percentage of preneoplastic pancreatic intraductal neoplasia lesions lost rap1GAP expression, whereas loss of rap1GAP expression occurred in 60 % of invasive pancreatic cancers, suggesting that rap1GAP contributes to pancreatic cancer progression. In vitro and in vivo studies showed that loss of rap1GAP promotes pancreatic cancer growth, survival, and invasion, and may function through modulation of integrin activity. Furthermore, we showed a high frequency of loss of heteroz...
Multiple Endocrine Neoplasia Type I Syndrome (MEN 1) is a monogenic autosomal dominantly inherited c...
Pancreatic adenocarcinoma displays a variety of molecular changes that evolve exponentially with tim...
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently asso...
<p>Signaling from the G protein, Rap1 is involved in several fundamental biological processes. Yet t...
The prospect that pancreatic cancer will be the second most common cause of cancer death by 2030 is ...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
Recent advances in molecular biology have revealed that a number of oncogenes (K-ras, erbB-2, and Me...
Pancreatic adenocarcinoma (PDAC) is driven by somatic genetic alterations. Functional studies are es...
Pancreatic ductal adenocarcinoma has a heterogeneous genetic landscape, marked by frequent mutation ...
Background: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gene e...
International audiencePancreatic adenocarcinoma is one of the most aggressive human cancers. It disp...
BACKGROUND: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gen...
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most fatal cancer types with a very...
Purpose: Pancreatic neuroendocrine tumors are a major manifestation of multiple endocrine neoplasia ...
International audienceThe understanding of the biology of pancreatic carcinoma has greatly benefited...
Multiple Endocrine Neoplasia Type I Syndrome (MEN 1) is a monogenic autosomal dominantly inherited c...
Pancreatic adenocarcinoma displays a variety of molecular changes that evolve exponentially with tim...
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently asso...
<p>Signaling from the G protein, Rap1 is involved in several fundamental biological processes. Yet t...
The prospect that pancreatic cancer will be the second most common cause of cancer death by 2030 is ...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
Recent advances in molecular biology have revealed that a number of oncogenes (K-ras, erbB-2, and Me...
Pancreatic adenocarcinoma (PDAC) is driven by somatic genetic alterations. Functional studies are es...
Pancreatic ductal adenocarcinoma has a heterogeneous genetic landscape, marked by frequent mutation ...
Background: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gene e...
International audiencePancreatic adenocarcinoma is one of the most aggressive human cancers. It disp...
BACKGROUND: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gen...
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most fatal cancer types with a very...
Purpose: Pancreatic neuroendocrine tumors are a major manifestation of multiple endocrine neoplasia ...
International audienceThe understanding of the biology of pancreatic carcinoma has greatly benefited...
Multiple Endocrine Neoplasia Type I Syndrome (MEN 1) is a monogenic autosomal dominantly inherited c...
Pancreatic adenocarcinoma displays a variety of molecular changes that evolve exponentially with tim...
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is frequently asso...